Transcriptome Sequencing Reveals the Potential Mechanisms of Modified Electroconvulsive Therapy in Schizophrenia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective Schizophrenia (SCZ) is one of the most common and severe mental disorders. Modified electroconvulsive therapy (MECT) is the most effective therapy for all kinds of SCZ, and the underlying molecular mechanism remains unclear. This study is aim to detect the molecule mechanism by constructing the transcriptome dataset from SCZ patients treated with MECT and health controls (HCs).Methods Transcriptome sequencing was performed on blood samples of 8 SCZ (BECT: before MECT; AECT: after MECT) and 8 HCs, weighted gene co-expression network analysis (WGCNA) was used to cluster the different expression genes, enrichment and protein-protein interaction (PPI) enrichment analysis were used to detect the related pathways.Results Three gene modules (black, blue and turquoise) were significantly associated with MECT, enrichment analysis found that the long-term potentiation pathway was associated with MECT. PPI enrichment p-value of black, blue, turquoise module are 0.00127, <1×10<sup>-16</sup> and 1.09×10<sup>-13</sup>, respectively. At the same time, EP300 is a key node in the PPI for genes in black module, which got from the transcriptome sequencing data.Conclusion It is suggested that the long-term potentiation pathways were associated with biological mechanism of MECT.
Abstract
Objective Schizophrenia (SCZ) is one of the most common and severe mental disorders. Modified electroconvulsive therapy (MECT) is the most effective therapy for all kinds of SCZ, and the underlying molecular mechanism remains unclear. This study is aim to detect the molecule mechanism by constructing the transcriptome dataset from SCZ patients treated with MECT and health controls (HCs).Methods Transcriptome sequencing was performed on blood samples of 8 SCZ (BECT: before MECT; AECT: after MECT) and 8 HCs, weighted gene co-expression network analysis (WGCNA) was used to cluster the different expression genes, enrichment and protein-protein interaction (PPI) enrichment analysis were used to detect the related pathways.Results Three gene modules (black, blue and turquoise) were significantly associated with MECT, enrichment analysis found that the long-term potentiation pathway was associated with MECT. PPI enrichment p-value of black, blue, turquoise module are 0.00127, <1×10<sup>-16</sup> and 1.09×10<sup>-13</sup>, respectively. At the same time, EP300 is a key node in the PPI for genes in black module, which got from the transcriptome sequencing data.Conclusion It is suggested that the long-term potentiation pathways were associated with biological mechanism of MECT.
참고문헌 (35)
- Fatima W, "Chromosomal region 1q24. 1 is associated with increased risk of schizophrenia in Pakistani population", Gene, 734, pp.144390~ (2020)
- Leucht S, "Definitions of response and remission in schizophrenia : recommendations for their use and their presentation", Acta Psychiatr Scand Suppl, (438), pp.7~14 (2009)
- Leucht S, "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia : a multiple-treatments meta-analysis", Lancet, 382, pp.951~962 (2013)
- Oehl M, "Compliance with antipsychotic treatment", Acta Psychiatr Scand Suppl, (407), pp.83~86 (2000)
- Tang YL, "Electroconvulsive therapy in China : clinical practice and research on efficacy", J ECT, 28, pp.206~212 (2012)
- Tharyan P, "Electroconvulsive therapy for schizophrenia", Cochrane Database Syst Rev, (2), pp.CD000076~ (2005)
- Kaneko T, "Microarray analysis of human blood during electroconvulsive therapy", J ECT, 31, pp.234~237 (2015)
- Benros ME, "Autoimmune diseases and severe infections as risk factors for schizophrenia : a 30-year population-based register study", Am J Psychiatry, 168, pp.1303~1310 (2011)
- First MB, "User’s Guide for the Structured Clinical Interview for DSMIV Axis II Personality Disorders: SCID-II", pp.91~ (1997), American Psychiatric Press
- Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Guo YF, "Effects of the modified electric convulsive treatment(MECT)on cell factors of schizophrenia", Exp Ther Med, 13, pp.873~876 (2017)
- Robinson MD, "edgeR : a Bioconductor package for differential expression analysis of digital gene expression data", Bioinformatics, 26, pp.139~140 (2010)
- Langfelder P, "WGCNA : an R package for weighted correlation network analysis", BMC Bioinformatics, 9, pp.559~ (2008)
- Liao Y, "WebGestalt 2019 : gene set analysis toolkit with revamped UIs and APIs", Nucleic Acids Res, 47, pp.W199~ (2019)
- Szklarczyk D, "The STRING database in 2017 : quality-controlled protein-protein association networks, made broadly accessible", Nucleic Acids Res, 45, pp.D362~ (2017)
- Scardoni G, "Analyzing biological network parameters with CentiScaPe", Bioinformatics, 25, pp.2857~2859 (2009)
- Masaki Nishiguchi, "Increases in iPS Transcription Factor (Oct4, Sox2, c-Myc, and Klf4) Gene Expression after Modified Electroconvulsive Therapy", PSYCHIATRY INVESTIGATION, 12(4), pp.532~537 (2015), 대한신경정신의학회[DOI]
- Gonçalves VF, "A comprehensive analysis of nuclear-encoded mitochondrial genes in schizophrenia", Biol Psychiatry, 83, pp.780~789 (2018)
- Grasselli G, "Cerebellar long-term potentiation : cellular mechanisms and role in learning", Int Rev Neurobiol, 117, pp.39~51 (2014)
- Wang Z, "Axon guidance pathway genes are associated with schizophrenia risk", Exp Ther Med, 16, pp.4519~4526 (2018)
- Galvez V, "Health Related Quality of Life after ECT for depression : a study exploring the role of different electrode-placements and pulse-widths", J Affect Disord, 206, pp.268~272 (2016)
- Weiner RD, "Key updates in the clinical application of electroconvulsive therapy", Int Rev Psychiatry, 29, pp.54~62 (2017)
- Kirov GG, "Evaluation of cumulative cognitive deficits from electroconvulsive therapy", Br J Psychiatry, 208, pp.266~270 (2016)
- Salavati B, "Imaging-based neurochemistry in schizophrenia : a systematic review and implications for dysfunctional long-term potentiation", Schizophr Bull, 41, pp.44~56 (2015)
- Sibarov DA, "Calcium-Dependent Desensitization of NMDA Receptors", Biochemistry(Mosc), 83, pp.1173~1183 (2018)
- Gardea-Resendez M, "Dissecting the epigenetic changes induced by non-antipsychotic mood stabilizers on schizophrenia and affective disorders : a systematic review", Front Pharmacol, 11, pp.467~ (2020)
- Dyrvig M, "DNA methylation regulates CHRNA7 transcription and can be modulated by valproate", Neurosci Lett, 704, pp.145~152 (2019)
- Paulsen Bda S, "Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells", Schizophr Res, 154, pp.30~35 (2014)
- Rinaldi T, "Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid", Proc Natl Acad Sci U S A, 104, pp.13501~13506 (2007)
- Wang WP, "The EP300, KDM5A, KDM6A and KDM6B chromatin regulators cooperate with KLF4 in the transcriptional activation of POU5F1", PLoS One, 7, pp.e52556~ (2012)
- Whitton L, "Cognitive analysis of schizophrenia risk genes that function as epigenetic regulators of gene expression", Am J Med Genet B Neuropsychiatr Genet, 171, pp.1170~1179 (2016)
- Hadjidaniel MD, "Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC", Oncotarget, 8, pp.91516~91529 (2017)
- Erk S, "Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomains", Transl Psychiatry, 7, pp.e997~ (2017)
- Girard SL, "Mutation burden of rare variants in schizophrenia candidate genes", PLoS One, 10, pp.e0128988~ (2015)
- Roelfsema JH, "Genetic heterogeneity in Rubinstein-Taybi syndrome : mutations in both the CBP and EP300 genes cause disease", Am J Hum Genet, 76, pp.572~580 (2005)